Inhibition of peptidoglycan biosynthesis by ramoplanin.
Ramoplanin, a new lipoglycopeptide antibiotic, inhibits cell wall peptidoglycan biosynthesis in gram-positive bacteria. In both Staphylococcus aureus and Bacillus megaterium, UDP-N-acetylmuramyl-pentapeptides (UDP-MurNAc-pentapeptides) accumulated at concentrations of ramoplanin close to the MIC, in...
Tallennettuna:
| Julkaisussa: | Antimicrob Agents Chemother |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology (ASM)
1990
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC171607/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2334153/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.34.3.413 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
